I agree that $42,000/yr is too much (and the article did mention they have a global plan). but as to ridiculously expensive trials etc... Is it harder for a co

I agree that $42,000/yr is too much (and the article did mention they have a global plan). but as to ridiculously expensive trials etc... Is it harder for a company to get funded to drive a disease to extinction?